88587-94-4 Usage
Description
1-hexadecyl-2-palmitoyl-sn-glycero-3-phosphocholine is a type of 2-acyl-1-alkyl-sn-glycero-3-phosphocholine, which is a class of glycerophospholipids. It consists of a hexadecanoyl (palmitoyl) acyl group and a hexadecyl alkyl group. 1-hexadecyl-2-palmitoyl-sn-glycero-3-phosphocholine plays a crucial role in the structure and function of cell membranes.
Uses
Used in Pharmaceutical Industry:
1-hexadecyl-2-palmitoyl-sn-glycero-3-phosphocholine is used as a pharmaceutical agent for its potential therapeutic effects. It has been studied for its ability to modulate cellular processes and may have applications in the treatment of various diseases.
Used in Cosmetic Industry:
In the cosmetic industry, 1-hexadecyl-2-palmitoyl-sn-glycero-3-phosphocholine is used as an emulsifying agent. It helps to stabilize formulations by reducing the surface tension between oil and water, allowing for the creation of homogeneous mixtures.
Used in Research:
1-hexadecyl-2-palmitoyl-sn-glycero-3-phosphocholine is also used in research settings as a model compound to study the properties and functions of glycerophospholipids in biological systems. This helps scientists to better understand the role of these lipids in cellular processes and their potential as therapeutic targets.
Check Digit Verification of cas no
The CAS Registry Mumber 88587-94-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,5,8 and 7 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 88587-94:
(7*8)+(6*8)+(5*5)+(4*8)+(3*7)+(2*9)+(1*4)=204
204 % 10 = 4
So 88587-94-4 is a valid CAS Registry Number.
InChI:InChI=1/C40H82NO7P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-35-45-37-39(38-47-49(43,44)46-36-34-41(3,4)5)48-40(42)33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h39H,6-38H2,1-5H3/t39-/m1/s1
88587-94-4Relevant articles and documents
Enzymatic Release of Antitumor Ether Lipids by Specific Phospholipase A2 Activation of Liposome-Forming Prodrugs
Andresen, Thomas L.,Davidsen, Jesper,Begtrup, Mikael,Mouritsen, Ole G.,J?rgensen, Kent
, p. 1694 - 1703 (2004)
An enzymatically activated liposome-based drug-delivery concept involving masked antitumor ether lipids (AELs) has been investigated. This concept takes advantage of the cytotoxic properties of AEL drugs as well as the membrane permeability enhancing prop
